Mean age of presentation is 14 month€¦ · • Responsible for app. 1% of pediatric hypertension...

25

Transcript of Mean age of presentation is 14 month€¦ · • Responsible for app. 1% of pediatric hypertension...

Page 1: Mean age of presentation is 14 month€¦ · • Responsible for app. 1% of pediatric hypertension • Bilateral tumors in 25-34 % • Malignant in 12-56% in pediatric patients (criteria:
Page 2: Mean age of presentation is 14 month€¦ · • Responsible for app. 1% of pediatric hypertension • Bilateral tumors in 25-34 % • Malignant in 12-56% in pediatric patients (criteria:
Page 3: Mean age of presentation is 14 month€¦ · • Responsible for app. 1% of pediatric hypertension • Bilateral tumors in 25-34 % • Malignant in 12-56% in pediatric patients (criteria:

• Mean age of presentation is 14 month

Page 4: Mean age of presentation is 14 month€¦ · • Responsible for app. 1% of pediatric hypertension • Bilateral tumors in 25-34 % • Malignant in 12-56% in pediatric patients (criteria:
Page 5: Mean age of presentation is 14 month€¦ · • Responsible for app. 1% of pediatric hypertension • Bilateral tumors in 25-34 % • Malignant in 12-56% in pediatric patients (criteria:
Page 6: Mean age of presentation is 14 month€¦ · • Responsible for app. 1% of pediatric hypertension • Bilateral tumors in 25-34 % • Malignant in 12-56% in pediatric patients (criteria:
Page 7: Mean age of presentation is 14 month€¦ · • Responsible for app. 1% of pediatric hypertension • Bilateral tumors in 25-34 % • Malignant in 12-56% in pediatric patients (criteria:
Page 8: Mean age of presentation is 14 month€¦ · • Responsible for app. 1% of pediatric hypertension • Bilateral tumors in 25-34 % • Malignant in 12-56% in pediatric patients (criteria:
Page 9: Mean age of presentation is 14 month€¦ · • Responsible for app. 1% of pediatric hypertension • Bilateral tumors in 25-34 % • Malignant in 12-56% in pediatric patients (criteria:
Page 10: Mean age of presentation is 14 month€¦ · • Responsible for app. 1% of pediatric hypertension • Bilateral tumors in 25-34 % • Malignant in 12-56% in pediatric patients (criteria:
Page 11: Mean age of presentation is 14 month€¦ · • Responsible for app. 1% of pediatric hypertension • Bilateral tumors in 25-34 % • Malignant in 12-56% in pediatric patients (criteria:
Page 12: Mean age of presentation is 14 month€¦ · • Responsible for app. 1% of pediatric hypertension • Bilateral tumors in 25-34 % • Malignant in 12-56% in pediatric patients (criteria:
Page 13: Mean age of presentation is 14 month€¦ · • Responsible for app. 1% of pediatric hypertension • Bilateral tumors in 25-34 % • Malignant in 12-56% in pediatric patients (criteria:
Page 14: Mean age of presentation is 14 month€¦ · • Responsible for app. 1% of pediatric hypertension • Bilateral tumors in 25-34 % • Malignant in 12-56% in pediatric patients (criteria:
Page 15: Mean age of presentation is 14 month€¦ · • Responsible for app. 1% of pediatric hypertension • Bilateral tumors in 25-34 % • Malignant in 12-56% in pediatric patients (criteria:
Page 16: Mean age of presentation is 14 month€¦ · • Responsible for app. 1% of pediatric hypertension • Bilateral tumors in 25-34 % • Malignant in 12-56% in pediatric patients (criteria:
Page 17: Mean age of presentation is 14 month€¦ · • Responsible for app. 1% of pediatric hypertension • Bilateral tumors in 25-34 % • Malignant in 12-56% in pediatric patients (criteria:
Page 18: Mean age of presentation is 14 month€¦ · • Responsible for app. 1% of pediatric hypertension • Bilateral tumors in 25-34 % • Malignant in 12-56% in pediatric patients (criteria:
Page 19: Mean age of presentation is 14 month€¦ · • Responsible for app. 1% of pediatric hypertension • Bilateral tumors in 25-34 % • Malignant in 12-56% in pediatric patients (criteria:
Page 20: Mean age of presentation is 14 month€¦ · • Responsible for app. 1% of pediatric hypertension • Bilateral tumors in 25-34 % • Malignant in 12-56% in pediatric patients (criteria:

• Responsible for app. 1% of pediatric hypertension

• Bilateral tumors in 25-34 %

• Malignant in 12-56% in pediatric patients (criteria: tumor invasion and distant metastasis)

Page 21: Mean age of presentation is 14 month€¦ · • Responsible for app. 1% of pediatric hypertension • Bilateral tumors in 25-34 % • Malignant in 12-56% in pediatric patients (criteria:
Page 22: Mean age of presentation is 14 month€¦ · • Responsible for app. 1% of pediatric hypertension • Bilateral tumors in 25-34 % • Malignant in 12-56% in pediatric patients (criteria:
Page 23: Mean age of presentation is 14 month€¦ · • Responsible for app. 1% of pediatric hypertension • Bilateral tumors in 25-34 % • Malignant in 12-56% in pediatric patients (criteria:

MIBG scan

Page 24: Mean age of presentation is 14 month€¦ · • Responsible for app. 1% of pediatric hypertension • Bilateral tumors in 25-34 % • Malignant in 12-56% in pediatric patients (criteria:
Page 25: Mean age of presentation is 14 month€¦ · • Responsible for app. 1% of pediatric hypertension • Bilateral tumors in 25-34 % • Malignant in 12-56% in pediatric patients (criteria:

Malignant Salivary Gland Tumors

Malignant Salivary Gland Tumors

Malignant Tumors of the Skin

Malignant Tumors of the Skin

Malignant ovarian tumors

Malignant ovarian tumors

Pediatric Tumors

Pediatric Tumors

Malignant skin tumors

Malignant skin tumors

Skin Adnexal Tumors-An Overview - Patologi Tumors of the Skin Overview.pdf · skin Malignant mixed tumors. Histologic Clues for Benign vs. Malignant Benign Malignant Vertically oriented

Skin Adnexal Tumors-An Overview - Patologi Tumors of the Skin Overview.pdf · skin Malignant mixed tumors. Histologic Clues for Benign vs. Malignant Benign Malignant Vertically oriented

Malignant Cervical Spine Tumors Operative treatment

Malignant Cervical Spine Tumors Operative treatment

Malignant epthelial tumors of the lung

Malignant epthelial tumors of the lung

Tumors. Tumors Adenoma (Benign) Carcinomas (malignant) Others.

Tumors. Tumors Adenoma (Benign) Carcinomas (malignant) Others.

Malignant Tumors of Larynx

Malignant Tumors of Larynx

Malignant Tumors

Malignant Tumors

MALIGNANT PERIVASCULAR EPITHELIOID CELL TUMORS …

MALIGNANT PERIVASCULAR EPITHELIOID CELL TUMORS …

Malignant bone Tumors,Radiology

Malignant bone Tumors,Radiology

Skin Tumors Benign and Malignant

Skin Tumors Benign and Malignant

Thyroid - Malignant tumors

Thyroid - Malignant tumors

Malignant Breast Tumors Oke

Malignant Breast Tumors Oke

Alternative lengthening of telomeres is enriched in, and impacts survival of TP53 mutant pediatric malignant brain tumors

Alternative lengthening of telomeres is enriched in, and impacts survival of TP53 mutant pediatric malignant brain tumors

Pediatric malignant solid tumors christosova,brankov

Pediatric malignant solid tumors christosova,brankov

Malignant Renal Tumors Part One

Malignant Renal Tumors Part One

Brain Tumors: Malignant vs. Benign

Brain Tumors: Malignant vs. Benign